Cannabis Bioscience International Holdings, Inc. (CBIH) Net Equity Issued and Repurchased (2023 - 2025)

Cannabis Bioscience International Holdings has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $124250.0 in Q2 2025.

• Quarterly Net Equity Issued and Repurchased rose 2585.0% year-over-year to $124250.0 in Q2 2025, while the trailing twelve-month figure through Aug 2025 was $244250.0 (up 4985.0% YoY) and the FY2025 annual result came in at $244250.0, up 248.93% from the prior year.
• Net Equity Issued and Repurchased grew to $124250.0 in Q2 2025 per CBIH's latest filing, from $120000.0 in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $248300.0 in Q1 2023 and troughed at -$5000.0 in Q2 2024.
• A 3-year average of $121425.0 and a median of $122125.0 in 2025 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased sank 103.01% in 2024, then surged 2585.0% in 2025.
• Over 3 years, Net Equity Issued and Repurchased stood at $75000.0 in 2023, then tumbled by 106.67% to -$5000.0 in 2024, then soared by 2585.0% to $124250.0 in 2025.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $124250.0, $120000.0, and -$5000.0 for Q2 2025, Q1 2025, and Q2 2024 respectively.